SecBot SecBot
DEFA14A ·Filed Apr 27, 2026

FTRE

Fortrea Holdings Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001193125-26-178735
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard annual proxy filing. No immediate action or read-through is required for traders. Monitor future 10-Q and 10-K filings for any changes in guidance or financial performance.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
FTRE ▲ +74.43% at T+60d
NEUTRAL call +74.43% · α vs SPY +69.66% · entry $10.60 → $18.49
Entry = T+0 close
Apr 27, 2026
via day close
T+1d
+1.51%
call +1.51% · α +1.99%
$10.76
settled 6mo ago
T+5d
+15.57%
call +15.57% · α +15.17%
$12.25
settled 6mo ago
T+20d
+24.72%
call +24.72% · α +19.76%
$13.22
settled 5mo ago
T+60d
+74.43%
call +74.43% · α +69.66%
$18.49
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Fortrea Holdings Inc. filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, which includes the election of three directors, ratification of its auditor, and an advisory vote on executive compensation. This is a routine annual filing with no material financial impact.

Key Financial Metrics

Vote
director election
Meeting
2026-06-09

Key Facts

  • Filing is a routine annual proxy statement (DEFA14A) for the 2026 Annual Meeting.
  • Proposals include the election of three directors: Anshul Thakral, Peter M. Neupert, and William J. Sharbaugh.
  • Other items are the ratification of Deloitte & Touche LLP as the independent auditor and an advisory vote on executive compensation.
  • No material financial data, strategic changes, or activist involvement is disclosed.

Financial Impact

No immediate financial impact. Routine governance filing.

none

Risk Factors

  • None disclosed in this filing.
  • Routine governance filings do not signal any immediate risk to the company's operations or financial health.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
59% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-178735
Document: 0001193125-26-178735-index-headers.html0001193125-26-178735
Document: 0001193125-26-178735-index.html0001193125-26-178735
Document: 0001193125-26-178735.txt0001193125-26-178735
22 reports for FTRE
Performance horizon
100% Hit rate @ T+1 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +11.57%Feb 26, 2026
Filters
Rows
Reports for FTRE — sortable, filterable
TypeNow
Oct 27, 2026
today
Press Release
NEUTRAL ★ 2/10
$23.63awaiting T+1—$24.43 (+3.39%)
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 3/10
$23.63 $23.83▲ +0.85%▲ +0.14%$24.43 (+3.39%)
Oct 19, 2026
8d ago
Press Release
BULLISH ★ 5/10
$22.78 $24.06▲ +5.62%▲ +5.09%$24.43 (+7.24%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 1/10
$21.11 $20.78▼ −1.56%▼ −2.11%$24.43 (+15.73%)
Sep 30, 2026
27d ago
8-K
NEUTRAL ★ 2/10
$19.40 $20.00▲ +3.09%▲ +2.35%$24.43 (+25.93%)
Sep 10, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$17.20 $17.41▲ +1.22%▲ +1.67%$24.43 (+42.03%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$17.02 $17.20▲ +1.06%▲ +0.21%$24.43 (+43.54%)
Sep 2, 2026
7w ago
Press Release
BULLISH ★ 6/10
$18.36 $18.62▲ +1.42%▲ +0.37%$24.43 (+33.06%)
Aug 22, 2026
9w ago
Institutional Cluster
MIXED ★ 5/10
$18.31 $18.27▼ −0.22%▼ −0.54%$24.43 (+33.42%)
Aug 7, 2026
11w ago
Insider Cluster
MIXED ★ 5/10
$18.99 $19.52▲ +2.79%▲ +3.11%$24.43 (+28.65%)
Showing 10 of 22

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026